Rishi, PukhrajRishi, EktaShroff, Daraius2009-05-232009-05-292009-05-232009-05-292009-05-23Rishi P, Rishi E, Shroff D. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia. Indian Journal of Ophthalmology. 2009 May-Jun; 57(3): 241-2http://imsear.searo.who.int/handle/123456789/70491engAngiogenesis Inhibitors --therapeutic useAntibodies, Monoclonal --therapeutic useAntibodies, Monoclonal, HumanizedCombined Modality TherapyFluorescein AngiographyHumansInjectionsMaleMiddle AgedPhotochemotherapyRetinal Diseases --diagnosisRetinal Diseases --drug therapyRetinal Diseases --physiopathologyRetinal Neovascularization --diagnosisRetinal Neovascularization --drug therapyRetinal Neovascularization --physiopathologyRetinal Vessels --pathologyTelangiectasis --diagnosisTelangiectasis --drug therapyTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor A --antagonists & inhibitorsVisual AcuityVitreous BodyVascular Endothelial Growth Factor A --antagonists & inhibitorsVitreous BodyLetter